Skip Navigation

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
NIH HHS News Release Logo

National Institute of Allergy and
Infectious Diseases (NIAID)

Friday, Dec. 4, 1998

Media Contact:
John Bowersox (301) 402-1663
Jane DeMouy (301) 496-3583

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Maternal Tissue Typing Could Improve Selection of Kidney Transplant Donors

Researchers supported by the National Institutes of Health (NIH) have discovered that cellular markers, or human leukocyte antigens (HLA), on maternal tissue can provide valuable information for identifying the most suitable donors for individuals in need of kidney transplants. The new finding was reported Dec. 3, 1998, in The New England Journal of Medicine by a team of scientists led by William J. Burlingham, Ph.D., of the University of Wisconsin, Madison, and Michael A. Bean, M.D., of Dendreon Corporation, Mountain View, Calif.

"The simple addition of maternal HLA typing," says Dr. Burlingham, "to the routine family workup for living-related kidney donation will greatly expand the pool of optimal donors, by giving an alternative choice to the transplant surgeon in cases where an HLA-identical sibling is unavailable. Based on this finding, the University of Wisconsin plans to add maternal HLA typing to their pre-transplantation procedures."

To minimize the risk of transplant rejection, surgeons try to find donors who are genetically similar to the recipient. The best outcomes are achieved when the donor is the identical twin of the individual who needs a transplant. In the absence of an identical twin, other siblings, such as those who share identical HLA genes, usually provide the closest HLA match.

Dr. Burlingham’s research team compared transplant survival rates of kidneys donated by HLA-identical siblings of recipients with those donated by siblings who shared only half of the recipients’ HLA antigens. The researchers found that long-term survival rates of HLA-identical kidneys were the same as HLA-mismatched kidneys, provided the donors’ mismatched HLA antigens were inherited from the siblings’ mother rather than their father. Therefore, comparing the mother’s HLA type with those of the transplant candidate’s siblings will provide clues about which sibling would be the optimal organ donor.

The researchers hypothesize that prenatal exposure to maternal HLA molecules induces a long-lasting form of immune tolerance. Thus, when the recipient encounters the same HLA molecules in adult life via a sibling-donated kidney, this state of induced immune tolerance prevents rejection of the mismatched kidney.

"Finding ways to induce immune tolerance to foreign tissue is the ‘Holy Grail’ of transplantation researchers," notes Steve Rose, Ph.D., chief of NIAID’s genetics and transplantation branch. "This study could provide important new insights into mechanisms of immune tolerance."

This study was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).



WJ Burlingham, AP Grailer, DM Heisey, FHJ Claas, D Norman, T Mohanakumar, DC Brennan, H DeFijter, T VanGelder, JD Pirsch, HW Sollinger and MA Bean. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. NEJM 339, 1657-64 (1998).

F Sanfilippo. Transplantation tolerance - the search continues (editorial). NEJM 339, 1700-02 (1998).

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH...Turning Discovery Into Health ®

back to top


NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.

Last Updated December 04, 1998